Maxcyte, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
MXCT on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
9713 Key West Avenue,, Suite 400, Rockville, Maryland

Insiders trading volume in the past year

Maxcyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Casdin Partners Master Fund, L.P. 10%+ Owner $45.3 M Oct 3, 2022
Art Mandell Director $1.94 M Jun 11, 2024
Douglas Doerfler President and CEO, Director $1.51 M -$767 K -33.7% Dec 4, 2023
Stanley C. Erck Director $1.32 M Jun 11, 2024
Douglas Richard Director $595 K Jun 11, 2024
John Joseph Johnston Director $566 K -$235 K -29.4% Jun 27, 2024
J. Stark Thompson Phd Director $502 K Aug 9, 2021
Maher Masoud President and CEO, Director $490 K +$489 K +47298% Jun 7, 2024
Douglas Swirsky Chief Financial Officer $374 K Mar 15, 2024
William W. Brooke Director $351 K Jun 11, 2024
David I. Sandoval General Counsel $211 K Mar 15, 2024
Yasir B. Al-Wakeel Director $105 K Jun 11, 2024
Rekha Hemrajani Director $105 K Jun 11, 2024
Patrick J. Balthrop Director $105 K Jun 11, 2024
Thomas M. Ross Evp, Global Sales $101 K -$271 K -72.9% Jul 8, 2024
Cenk Sumen Chief Scientific Officer Apr 11, 2022
Ron Holtz Chief Financial Officer Mar 20, 2023
Amanda Louise Murphy Chief Financial Officer Mar 25, 2022

Recent Insider Transactions by Companies or Individuals for Maxcyte, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership